Trademark: 88920682
Word
XALTUBEQ
Status
Pending
Status Code
734
Status Date
Wednesday, November 8, 2023
Serial Number
88920682
Mark Type
4000
Filing Date
Monday, May 18, 2020
Published for Opposition
Tuesday, March 23, 2021

Trademark Owner History
Celgene Corporation - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Trademark Events
Nov 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 8, 2023
Sou Extension 5 Granted
Nov 3, 2023
Sou Extension 5 Filed
Nov 8, 2023
Case Assigned To Intent To Use Paralegal
Nov 3, 2023
Sou Teas Extension Received
May 2, 2023
Notice Of Approval Of Extension Request E-Mailed
Apr 28, 2023
Sou Extension 4 Granted
Apr 28, 2023
Sou Extension 4 Filed
Apr 28, 2023
Sou Teas Extension Received
Nov 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 9, 2022
Sou Extension 3 Granted
Nov 9, 2022
Sou Extension 3 Filed
Nov 9, 2022
Sou Teas Extension Received
May 11, 2022
Notice Of Approval Of Extension Request E-Mailed
May 9, 2022
Sou Extension 2 Granted
May 9, 2022
Sou Extension 2 Filed
May 9, 2022
Sou Teas Extension Received
Oct 22, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 20, 2021
Sou Extension 1 Granted
Oct 20, 2021
Sou Extension 1 Filed
Oct 20, 2021
Sou Teas Extension Received
May 18, 2021
Noa E-Mailed - Sou Required From Applicant
Mar 23, 2021
Official Gazette Publication Confirmation E-Mailed
Mar 23, 2021
Published For Opposition
Mar 3, 2021
Notification Of Notice Of Publication E-Mailed
Feb 13, 2021
Approved For Pub - Principal Register
Feb 10, 2021
Teas/Email Correspondence Entered
Feb 9, 2021
Correspondence Received In Law Office
Feb 9, 2021
Teas Response To Office Action Received
Aug 15, 2020
Notification Of Non-Final Action E-Mailed
Aug 15, 2020
Non-Final Action E-Mailed
Aug 15, 2020
Non-Final Action Written
Aug 15, 2020
Assigned To Examiner
Jun 2, 2020
New Application Office Supplied Data Entered
May 21, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24